Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting

NCT02463682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2016-04-11

No results posted yet for this study

Summary

This is a feasibility study of an artificial pancreas (AP) system with our previously validated Zone-MPC and Health Monitoring System (HMS) algorithms (ClinicalTraisl.gov: NCT01929798) integrated into the Diabetes Assistant (DiAs) system.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

CGM and Insulin Pump

Dexcom G4 Platinum CGM with Share AP Receiver Roche Accu-Chek insulin pump

DEVICE

Closed-Loop Control System

The devices that will be used in the Closed-Loop Control System include the following components: DiAs - a smart-phone medical platform; Dexcom Dexcom G4 Platinum connected to DiAs via Bluetooth CGM receiver; Roche Accu-Chek insulin pump connected to DiAs via wireless Bluetooth; Remote Monitoring Server connected to DiAs via 3G or local Wi-Fi network, and Zone-MPC and HMS algorithms running on DiAs (MPC and HMS)

Sponsors & Collaborators

  • University of California, Santa Barbara

    collaborator OTHER
  • Mayo Clinic

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • University of Padova

    collaborator OTHER
  • Sansum Diabetes Research Institute

    lead OTHER

Principal Investigators

  • Francis J Doyle III, PhD · University of California, Santa Barbara/William Sansum Diabetes Center

  • Eyal Dassau, PhD · University of California, Santa Barbara/William Sansum Diabetes Center

  • Jordan E Pinsker, MD · Sansum Diabetes Research Institute

  • Ananda Basu, MD · Mayo Clinic, Rochester, MN

  • Yogish Kudva, MD · Mayo Clinic, Rochester, MN

  • Boris Kovatchev, PhD · University of Virginia

  • Sue Brown, MD · University of Virginia

  • Stephen Patek, PhD · University of Virginia

  • Claudio Cobelli, PhD · University of Padova

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02463682 on ClinicalTrials.gov